Publication | Open Access

Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients ( > 55 to 70 years of age) with acute myelogenous leukemia

Hematological MalignancyGranulocyte Macrophage ColonyGranulocyteImmunologyHematologyEconomic AnalysisMedicineAcute Myelogenous Leukemia